Literature DB >> 9212717

Detection of endothelial cells by MEC 13.3 monoclonal antibody in mice mammary tumors.

S Vanzulli1, S Gazzaniga, M F Braidot, A Vecchi, A Mantovani, R Wainstok de Calmanovici.   

Abstract

In order to clearly visualize blood vessels, the monoclonal antibody (mAb) MEC 13.3 was used for an immunohistochemical staining on frozen sections of different mice mammary tumors. MEC 13.3 mAb is specific for endothelial cells (ECs) of mouse blood vessels and recognizes a molecule related to the murine form of CD31/PECAM. This mAb with immunoenzymatic technique or immunofluorescent labelling, was found to be a useful tool to quantify tumor neovascularization. Specifically, membrane reinforcement could be observed in vessel ECs, indicating the expression of CD31/ PECAM in their surface. The staining of ECs from tumors and from normal tissues was also compared. In this work, the use of MEC13.3 mAb is reported to recognize mice mammary tumor ECs as a useful tool to identify neovascularization. It would also be helpful for research on the origin and function of vascular endothelium in murine tumor experimental models.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9212717

Source DB:  PubMed          Journal:  Biocell        ISSN: 0327-9545            Impact factor:   1.254


  7 in total

1.  Immunohistochemistry in the evaluation of neovascularization in tumor xenografts.

Authors:  D Wang; C R Stockard; L Harkins; P Lott; C Salih; K Yuan; D Buchsbaum; A Hashim; M Zayzafoon; R W Hardy; O Hameed; W Grizzle; G P Siegal
Journal:  Biotech Histochem       Date:  2008-06       Impact factor: 1.718

2.  The mouse olfactory peduncle 4: Development of synapses, perineuronal nets, and capillaries.

Authors:  Lindsay N Collins; Peter C Brunjes
Journal:  J Comp Neurol       Date:  2019-10-18       Impact factor: 3.215

3.  Differential expression of components of the retinoic acid signaling pathway in the adult mouse olfactory epithelium.

Authors:  Carolyn E Peluso; Woochan Jang; Ursula C Dräger; James E Schwob
Journal:  J Comp Neurol       Date:  2012-11-01       Impact factor: 3.215

4.  Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases.

Authors:  Margaret Gil; Mukund Seshadri; Marcin P Komorowski; Scott I Abrams; Danuta Kozbor
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-18       Impact factor: 11.205

5.  Resveratrol worsens survival in SCID mice with prostate cancer xenografts in a cell-line specific manner, through paradoxical effects on oncogenic pathways.

Authors:  Joseph C Klink; Alok K Tewari; Elizabeth M Masko; Jodi Antonelli; Phillip G Febbo; Pinchas Cohen; Mark W Dewhirst; Salvatore V Pizzo; Stephen J Freedland
Journal:  Prostate       Date:  2012-11-28       Impact factor: 4.104

6.  Identification of protein targets in cerebral endothelial cells for brain arteriovenous malformation (AVMs) molecular therapies.

Authors:  Margaret Simonian; Rachel R Ogorzalek Loo; Nalaka Rannulu; Joseph A Loo; Mark P Molloy; Marcus A Stoodley
Journal:  Clin Proteomics       Date:  2017-05-16       Impact factor: 3.988

7.  Programmed death (PD)-1/PD-ligand 1 blockade mediates antiangiogenic effects by tumor-derived CXCL10/11 as a potential predictive biomarker.

Authors:  Atsushi Mitsuhashi; Kensuke Kondoh; Kazuki Horikawa; Kazuya Koyama; Na Thi Nguyen; Tania Afroj; Hiroto Yoneda; Kenji Otsuka; Hirokazu Ogino; Hiroshi Nokihara; Tsutomu Shinohara; Yasuhiko Nishioka
Journal:  Cancer Sci       Date:  2021-10-23       Impact factor: 6.716

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.